MedPath

Phase I/II clinical trial of stereotactic body radiotherapy in patients with cervical cancer who are unsuitable for intracavitary brachytherapy

Not Applicable
Conditions
terine cervical cancer
Registration Number
JPRN-UMIN000036845
Lead Sponsor
Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
21
Inclusion Criteria

Not provided

Exclusion Criteria

1. Serious medical or psychological problems 2. Other active cancer within 3 years 3. Be pregnant or just after giving birth

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Progression-free survival at 2 years
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath